Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first‐line treatment of patients with advanced breast cancer: Phase 3 randomized trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|19|3412-3421

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.19, 2015-10, pp. : 3412-3421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content